Article Versions Notes

Haghmorad D, Yousefi B, Eslami M, Rashidy-Pour A, Tarahomi M, Tavaf MJ, Soltanmohammadi A, Zargarani S, Kamyshnyi A, Oksenych V. RETRACTED: Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Current Issues in Molecular Biology. 2022; 44(11):5728-5740. https://doi.org/10.3390/cimb44110388

Haghmorad, Dariush, Bahman Yousefi, Majid Eslami, Ali Rashidy-Pour, Mahdieh Tarahomi, Maryam Jadid Tavaf, Azita Soltanmohammadi, Simin Zargarani, Aleksandr Kamyshnyi, and Valentyn Oksenych. 2022. "RETRACTED: Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses" Current Issues in Molecular Biology 44, no. 11: 5728-5740. https://doi.org/10.3390/cimb44110388

Haghmorad, D., Yousefi, B., Eslami, M., Rashidy-Pour, A., Tarahomi, M., Tavaf, M. J., Soltanmohammadi, A., Zargarani, S., Kamyshnyi, A., & Oksenych, V. (2022). RETRACTED: Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Current Issues in Molecular Biology, 44(11), 5728-5740. https://doi.org/10.3390/cimb44110388